UK markets closed
NIKKEI 225
39,103.22 +486.12 (+1.26%) HANG SENG
18,868.71 -326.89 (-1.70%) CRUDE OIL
77.28 -0.29 (-0.37%) GOLD FUTURES
2,345.80 -47.10 (-1.97%) DOW
39,399.76 -271.28 (-0.68%) Bitcoin GBP
53,531.94 -1,680.77 (-3.04%)
Talis Biomedical Corporation (TLIS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 12:17PM EDT. Market open.
| Previous close | 9.19 |
| Open | 9.27 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 9.09 - 9.27 |
| 52-week range | 4.35 - 9.60 |
| Volume | |
| Avg. volume | 8,201 |
| Market cap | 16.563M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -31.43 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireTalis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced it has initiated a process to explore strategic alternatives with the goal of maximizing shareholder value. While the Company has made progress developing the Talis One® system, it believes that this is a pr
© 2024 Yahoo. All rights reserved.